Literature DB >> 17191139

Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils.

W Gordon-Krajcer1, E Kozniewska, J W Lazarewicz, H Ksiezak-Reding.   

Abstract

Cortical neurons are vulnerable to ischemic insult, which may cause cytoskeletal changes and neurodegeneration. Tau is a microtubule-associated protein expressed in neuronal and glial cells. We examined the phosphorylation status of tau protein in the gerbil brain cortex during 5 min ischemia induced by bilateral common carotid artery occlusion followed by reperfusion for 20 min to 7 days. Control brain homogenates contained 63, 65 and 68 kD polypeptides of tau immunoreactive with Alz 50, Tau 14 and Tau 46 antibodies raised against non-phosphorylated tau epitopes. Gerbil tau was also immunoreactive with some (PHF-1 and 12E8) but not all (AT8, AT100, AT180 and AT270) antibodies raised against phosphorylated tau epitopes. PHF-1 recognized a single 68 kD polypeptide and 12E8 bound the 63 kD polypeptide. During 5 min ischemia, PHF-1 immunoreactivity declined to 6%, then recovered to control levels after 20 min of blood recirculation and subsequently increased above control values 3 and 7 days later. In contrast, 12E8 immunoreactivity remained stable during ischemia and reperfusion. Our results suggest that the two phosphorylated epitopes of tau are regulated by different mechanisms and may play different roles in microtubule dynamics. They may also define various pools of neuronal/glial cells vulnerable to ischemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17191139     DOI: 10.1007/s11064-006-9199-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  Dephosphorylation of tau during transient forebrain ischemia in the rat.

Authors:  D A Shackelford; R Y Yeh
Journal:  Mol Chem Neuropathol       Date:  1998 Jun-Aug

Review 2.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 3.  Poststroke dementia.

Authors:  H Hénon; F Pasquier; D Leys
Journal:  Cerebrovasc Dis       Date:  2006-04-26       Impact factor: 2.762

4.  Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205.

Authors:  W Gordon-Krajcer; L Yang; H Ksiezak-Reding
Journal:  Brain Res       Date:  2000-02-21       Impact factor: 3.252

5.  Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells.

Authors:  Alberto Gómez-Ramos; Javier Díaz-Nido; Mark A Smith; George Perry; Jesús Avila
Journal:  J Neurosci Res       Date:  2003-03-15       Impact factor: 4.164

6.  The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains.

Authors:  J Biernat; E M Mandelkow
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

7.  Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus.

Authors:  Qun Wang; Kenneth D Tompkins; Agnes Simonyi; Ronald J Korthuis; Albert Y Sun; Grace Y Sun
Journal:  Brain Res       Date:  2006-05-02       Impact factor: 3.252

8.  Metabolic disturbances of synaptosomes isolated from ischemic gerbil brain.

Authors:  K Domańska-Janik; J Lazarewicz; K Noremberg; J Strosznajder; T Zalewska
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

9.  Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356.

Authors:  J M Litersky; G V Johnson; R Jakes; M Goedert; M Lee; P Seubert
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

10.  Brain vasculature and mitochondrial responses to ischemia in gerbils. I. Basic anatomical patterns and biochemical correlates.

Authors:  A Mayevsky; Z Breuer
Journal:  Brain Res       Date:  1992-12-11       Impact factor: 3.252

View more
  21 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

2.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

3.  Oligemic hypoperfusion differentially affects tau and amyloid-{beta}.

Authors:  Maya A Koike; Kim N Green; Mathew Blurton-Jones; Frank M Laferla
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

Review 4.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

5.  The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.

Authors:  Batool Rizvi; Atul Narkhede; Briana S Last; Mariana Budge; Giuseppe Tosto; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman
Journal:  Neurobiol Aging       Date:  2017-12-16       Impact factor: 4.673

Review 6.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

7.  Ginsenoside Rd attenuates tau protein phosphorylation via the PI3K/AKT/GSK-3β pathway after transient forebrain ischemia.

Authors:  Xiao Zhang; Ming Shi; Ruidong Ye; Wei Wang; Xuedong Liu; Guangyun Zhang; Junliang Han; Yunxia Zhang; Bing Wang; Jun Zhao; Juan Hui; Lize Xiong; Gang Zhao
Journal:  Neurochem Res       Date:  2014-05-03       Impact factor: 3.996

8.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 9.  New therapeutic targets in the neurovascular pathway in Alzheimer's disease.

Authors:  Berislav V Zlokovic
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

10.  Neuropathologic basis of white matter hyperintensity accumulation with advanced age.

Authors:  Deniz Erten-Lyons; Randall Woltjer; Jeffrey Kaye; Nora Mattek; Hiroko H Dodge; Sarah Green; Huong Tran; Diane B Howieson; Katherine Wild; Lisa C Silbert
Journal:  Neurology       Date:  2013-08-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.